James H. Feusner

9.5k total citations · 1 hit paper
149 papers, 6.1k citations indexed

About

James H. Feusner is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, James H. Feusner has authored 149 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 63 papers in Hematology and 53 papers in Public Health, Environmental and Occupational Health. Recurrent topics in James H. Feusner's work include Acute Myeloid Leukemia Research (51 papers), Acute Lymphoblastic Leukemia research (49 papers) and Retinoids in leukemia and cellular processes (44 papers). James H. Feusner is often cited by papers focused on Acute Myeloid Leukemia Research (51 papers), Acute Lymphoblastic Leukemia research (49 papers) and Retinoids in leukemia and cellular processes (44 papers). James H. Feusner collaborates with scholars based in United States, Canada and Israel. James H. Feusner's co-authors include Martin S. Tallman, Jacob M. Rowe, Frederick R. Appelbaum, Cheryl L. Willman, Peter H. Wiernik, Lois E. Shepherd, Charles A. Schiffer, Milton J. Finegold, Mark Krailo and Angela Ogden and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

James H. Feusner

144 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

1997 806 citations Martin S. Tallman, Janet W. Andersen et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by James H. Feusner

Since Specialization

Citations

This map shows the geographic impact of James H. Feusner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James H. Feusner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James H. Feusner more than expected).

Fields of papers citing papers by James H. Feusner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James H. Feusner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James H. Feusner. The network helps show where James H. Feusner may publish in the future.

Co-authorship network of co-authors of James H. Feusner

This figure shows the co-authorship network connecting the top 25 collaborators of James H. Feusner. A scholar is included among the top collaborators of James H. Feusner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James H. Feusner. James H. Feusner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Obesity in children with acute promyelocytic leukemia: What is its prevalence and prognostic significance? 2022 ·Pediatric Blood & Cancer ·(unknown), Paul Lee, Alfred Rademaker, Todd A. Alonzo, Yicheng Wang, Bayard L. Powell, Diana Wu, Richard A. Larson, Matthew A. Kutny, John Gregory, Nobuko Hijiya, James H. Feusner	2
2	Zinc deficiency and its association with treatment‐related toxicity in children with cancer 2021 ·Pediatric Blood & Cancer ·Jong Chung, (unknown), Caroline A. Hastings, David W. Killilea, James H. Feusner, Ellen B. Fung	1
3	Hepatoblastoma in Children With Beckwith-Wiedemann Syndrome 2014 ·Journal of Pediatric Hematology/Oncology ·Angela D. Trobaugh‐Lotrario, Rajkumar Venkatramani, James H. Feusner	30
4	Treatment of Hepatoblastoma With High-dose Chemotherapy and Stem Cell Rescue 2014 ·Journal of Pediatric Hematology/Oncology ·Erin E. Karski, Christopher C. Dvorak, Wing Leung, Weston P. Miller, Peter J. Shaw, Muna Qayed, Emmanuel Katsanis, James H. Feusner	9
5	Weekend Delay in Initiation of Chemotherapy for Acute Lymphoblastic Leukemia 2012 ·Journal of Pediatric Hematology/Oncology ·(unknown), Ginny Gildengorin, James H. Feusner	11
6	The Utility of Routine Surveillance Blood Cultures in Asymptomatic Hematopoietic Stem Cell Transplant Patients 2010 ·Journal of Pediatric Hematology/Oncology ·(unknown), Ami J. Shah, Rita Secola, Mark Hudes, James H. Feusner	6
7	Twice Weekly Pneumocystis jiroveci Pneumonia Prophylaxis With Trimethoprim-Sulfamethoxazole in Pediatric Patients With Acute Lymphoblastic Leukemia 2010 ·Journal of Pediatric Hematology/Oncology ·Anurag K. Agrawal, Patrick P. Chang, James H. Feusner	16
8	Rhabdoid tumors of the liver: Rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy 2010 ·Pediatric Blood & Cancer ·Angela D. Trobaugh‐Lotrario, Milton J. Finegold, James H. Feusner	33
9	Treatment of children with acute promyelocytic leukemia: Results of the first North American intergroup trial INT0129 2009 ·Pediatric Blood & Cancer ·John Gregory, Haesook Kim, Todd A. Alonzo, (unknown), William G. Woods, Howard J. Weinstein, Lois E. Shepherd, Charles A. Schiffer, Frederick R. Appelbaum, Cheryl L. Willman, Peter H. Wiernik, Jacob M. Rowe, Martin S. Tallman, James H. Feusner	30
10	Isolated central nervous system recurrence of acute promyelocytic leukemia in children 2008 ·Pediatric Blood & Cancer ·Jessica Chow, James H. Feusner	17
11	Randomized comparison of antibiotics with and without granulocyte colony‐stimulating factor in children with chemotherapy‐induced febrile neutropenia: A report from the Children's Oncology Group 2005 ·Pediatric Blood & Cancer ·M. Fevzi Özkaynak, Mark Krailo, Zhengjia Chen, James H. Feusner	24
12	Progenitor cell involvement is predictive of response to induction chemotherapy in paediatric acute myeloid leukaemia 2003 ·British Journal of Haematology ·Donna L. Johnston, Soheil Meshinchi, Kent E. Opheim, Maria G. Pallavicini, James H. Feusner, William G. Woods, Beverly J. Lange, Jerald P. Radich, Irwin D. Bernstein	8
13	Infectious complications of intensive chemotherapy on children's cancer group protocol CCG-2961 for pediatric acute myeloid leukemia 2002 ·Blood ·James H. Feusner, Todd A. Alonzo, Patricia A. Dinndorf, Franklin O. Smith, R.J. Arceci	4
14	Use of Tissue Plasminogen Activator (rt-PA) in Young Children With Cancer and Dysfunctional Central Venous Catheters 2002 ·Journal of Pediatric Hematology/Oncology ·Louis Chesler, James H. Feusner	34
15	Randomized Comparison of Cisplatin/Vincristine/Fluorouracil and Cisplatin/Continuous Infusion Doxorubicin for Treatment of Pediatric Hepatoblastoma: A Report From the Children’s Cancer Group and the Pediatric Oncology Group 2000 ·Journal of Clinical Oncology ·Jorge A. Ortega, Edwin C. Douglass, James H. Feusner, Marleta Reynolds, John J. Quinn, Milton J. Finegold, Joel E. Haas, Denis R. King, Wen Liu‐Mares, Martha G. Sensel, Mark Krailo	234
16	All-trans-Retinoic Acid in Acute Promyelocytic Leukemia breakdown → 1997 ·New England Journal of Medicine ·Martin S. Tallman, Janet W. Andersen, Charles A. Schiffer, Frederick R. Appelbaum, James H. Feusner, Angela Ogden, Lois E. Shepherd, Cheryl L. Willman, Clara D. Bloomfield, Jacob M. Rowe, Peter H. Wiernik	806
17	Treatment of overt isolated testicular relapse in children on therapy for acute lymphoblastic leukemia. A report from the childrens cancer group 1994 ·Cancer ·Jerry Z. Finklestein, Denis R. Miller, James H. Feusner, Daniel O. Stram, Edward S. Baum, (unknown), Dale G. Johnson, Michael T. Gyepes, G. Denman Hammond	15
18	Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer. 1992 ·Journal of Clinical Oncology ·Malcolm A. Smith, Peter C. Adamson, Frank M. Balis, James H. Feusner, (unknown), Robert F. Murphy, Marc E. Horowitz, Gregory H. Reaman, G. Denman Hammond, (unknown)	119
19	Fatal Epstein-Barr virus-induced lymphoproliferation complicating acute lymphoblastic leukemia 1984 ·The Journal of Pediatrics ·(unknown), James H. Feusner, Shinji Harada, Warren G. Sanger, (unknown), Joanne Yetz, Ari K. Saemundsen, (unknown), James Linder, Janet K. Seeley, Bertram H. Lubin, David T. Purtilo	19
20	Association of hemorrhagic disease and the syndrome of persistent fetal circulation with the fetal hydantoin syndrome 1980 ·The Journal of Pediatrics ·William E. Truog, James H. Feusner, Dan L. Baker	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact